OneDigital Investment Advisors LLC Takes $736,000 Position in Celcuity, Inc. $CELC

OneDigital Investment Advisors LLC acquired a new stake in shares of Celcuity, Inc. (NASDAQ:CELC) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 7,031 shares of the company’s stock, valued at approximately $736,000.

A number of other large investors also recently bought and sold shares of the business. EverSource Wealth Advisors LLC lifted its holdings in Celcuity by 1,329.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 343 shares of the company’s stock worth $34,000 after buying an additional 319 shares during the period. US Bancorp DE increased its holdings in shares of Celcuity by 25.4% in the 3rd quarter. US Bancorp DE now owns 706 shares of the company’s stock valued at $35,000 after acquiring an additional 143 shares during the period. BNP Paribas Financial Markets raised its position in shares of Celcuity by 78.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 2,647 shares of the company’s stock worth $35,000 after acquiring an additional 1,167 shares in the last quarter. Parallel Advisors LLC bought a new position in shares of Celcuity in the 1st quarter worth $38,000. Finally, Meeder Asset Management Inc. purchased a new stake in shares of Celcuity during the 4th quarter worth $42,000. Institutional investors own 63.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on CELC shares. Leerink Partners set a $155.00 target price on Celcuity in a research note on Tuesday, June 2nd. HC Wainwright restated a “buy” rating and issued a $155.00 price target on shares of Celcuity in a report on Friday, August 14th. Needham & Company LLC cut their price objective on shares of Celcuity from $157.00 to $140.00 and set a “buy” rating on the stock in a research report on Friday, August 14th. Macquarie Infrastructure set a $160.00 price objective on shares of Celcuity in a research note on Thursday, May 28th. Finally, Wells Fargo & Company reduced their price objective on shares of Celcuity from $183.00 to $166.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Ten research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Celcuity has an average rating of “Moderate Buy” and a consensus target price of $154.55.

Celcuity Trading Up 0.9%

Shares of NASDAQ:CELC opened at $93.24 on Wednesday. The business’s 50-day moving average is $94.00 and its 200 day moving average is $108.08. The company has a debt-to-equity ratio of 6.04, a current ratio of 8.93 and a quick ratio of 8.93. Celcuity, Inc. has a 1 year low of $44.42 and a 1 year high of $151.02. The firm has a market capitalization of $4.55 billion, a P/E ratio of -21.68 and a beta of 0.21.

Celcuity (NASDAQ:CELC) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($1.44) earnings per share for the quarter, missing the consensus estimate of ($1.16) by ($0.28). On average, research analysts predict that Celcuity, Inc. will post -4.18 earnings per share for the current fiscal year.

Celcuity Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.